Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Arcadia Biosciences, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 24 | 29 | +5 |
| Shares | 3.28M | 2.37M | −916.5K (−27.9%) |
| Value | $1.73M | $639.5K | −$1.09M (−63.1%) |
New holders (8)
Institutions that held Arcadia Biosciences, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 181,437 | $49.2K | 0.00% |
| HRT Financial LP | 83,183 | $22.0K | 0.00% |
| Ergoteles LLC | 46,534 | $12.6K | 0.00% |
| Virtu Financial LLC | 13,123 | $4.00K | 0.00% |
| Goldman Sachs Group Inc | 11,033 | $2.99K | 0.00% |
| The PNC Financial Services Group, Inc. | 200 | $54 | 0.00% |
| Simplex Trading, LLC | 255 | $0 | 0.00% |
| VitalStone Financial, LLC | 4 | $0 | 0.00% |
Sold out (3)
Institutions that held Arcadia Biosciences, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Group AG | 15,675 | $8.00K |
| FMR LLC | 10,000 | $5.00K |
| Axiom Investment Management LLC | 1,500 | $1.00K |